Ignite Creation Date:
2024-05-05 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00479674
Status:
COMPLETED
Last Update Posted:
2015-02-18
First Post:
2007-05-25
Brief Title:
Phase II Study With Abraxane Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer
Sponsor:
Duke University
Organization:
Duke University
Organization Data
Organization:
Duke University
Class:
OTHER
Study ID:
Pro00014837
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Duke University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Celgene Corporation | INDUSTRY |
| Genentech Inc | INDUSTRY |